Saturday 17 October 2026 Export SGRY’s income statement to Excel — free account

Surgery Partners, Inc.

Surgery Partners, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 6.24% from fiscal 2024. In the quarter to June 2026, revenue grew 2.75%, EPS fell 500.0%, free cash flow fell 60.6% and total debt rose 4.92%, each against the same quarter a year earlier. Revenue growth for ten consecutive years; insiders bought in the last twelve months.

14.64 0.13 −0.88%

Follow SGRY

Alert me

Market cap: $1.9B
P/E: 0.0×
Fwd P/E: −94.9×
Dividend yield: —
F-score: 4/9
Altman Z: 0.75
Beneish M: −2.52
Dividend safety: 4/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 0.30

Total sells 1.28

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	2	—	—
Sell	—	—	—	—	11	—	—	—	—	—	—	—

Insider Ownership 39.45%

Capital & Financial Ratios $m

Market Cap 1,930.00

Revenue 3,366.30

Net Income 81.90

Free Cash Flow 191.50

Net Debt 3,534.50

Current Ratio 1.95

Debt/Equity 1.21

P/E ratio 0.00

Fwd P/E (94.90)

P/S ratio 0.56

P/B ratio 0.61

Past 5Y EPS Growth —

This Y EPS Growth (13.79%)

Next Y EPS Growth 6.46%

Next Y revenue growth (4.89%)

Next 5Y EPS Growth 8.37%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 32.25%

10-year low 10-year high

P/B against its own 10 years 23.77%

10-year low 10-year high

EV/Sales against its own 10 years 15.26%

10-year low 10-year high

EV/FCF against its own 10 years 39.92%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2017	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	196	270	240	217
Receivables	496	579	602	617
Inventory	75	88	97	99
Other	97	146	171	146
	895	1,119	1,151	1,126

	2023	2024	2025	Q'26
Payables	172	209	209	175
ST’ Debt	73	101	99	103
Other	204	254	243	227
	523	624	616	579

Compound Annual Growth %

	10y	5y	3y
Sales	13.17%	12.21%	9.22%
Cash Flow	12.50%	2.13%	19.98%
Earnings	0.00%	0.00%	0.00%
Book Value	26.52%	18.92%	2.11%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	811	849	—	—	—
’25	776	826	822	885	3,309
’24	717	762	770	864	3,114
’23	666	668	674	735	2,743
’22	596	615	621	707	2,539
’21	512	543	559	610	2,225
’20	441	375	496	548	1,860

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	12	59	—	—	—
’25	6	81	84	103	274
’24	41	83	65	111	300
’23	75	52	105	63	294
’22	80	42	30	7	159
’21	50	2	15	20	87
’20	29	182	27	9	247

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(4)	38	—	—	—
’25	(12)	96	64	94	242
’24	21	56	45	90	212
’23	58	44	85	43	231
’22	62	20	12	(3)	91
’21	38	(11)	(1)	9	36
’20	27	174	58	4	263

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(0.28)	(0.12)	—	—	—
’25	(0.30)	(0.02)	(0.18)	(0.12)	(0.61)
’24	(0.10)	(0.12)	(0.25)	(0.86)	(1.33)
’23	(0.20)	0.15	(0.04)	(0.01)	(0.09)
’22	0.14	(0.21)	(0.28)	(0.23)	(0.59)
’21	(0.57)	(0.39)	(0.28)	0.00	(1.12)
’20	(0.76)	(0.86)	(1.46)	(0.10)	(3.19)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	11.76	7.10	9.45	5.38	4.00	26.42	20.46	22.05	19.50	14.94	Analyst estimates 2026–2028 Powerpack
	High	20.93	24.05	19.95	16.18	29.46	69.58	63.87	45.79	35.30	26.16
People
People	Employees	6,000	10,600	11,000	9,600	10,800	10,900	12,200	13,500	15,000	16,000
	Revenue/emp, $m	0.19	0.13	0.16	0.19	0.17	0.20	0.21	0.20	0.21	0.21
Income, $m
Income, $m	Revenue	1,145	1,341	1,772	1,831	1,860	2,225	2,539	2,743	3,114	3,309
	Gross margin, %	28.31	24.41	23.15	23.14	20.42	22.08	22.64	23.60	23.94	23.12
	EBT	92	82	(69)	55	(19)	81	110	135	147	117
	EBT margin, %	8.05	6.14	(3.91)	2.98	(1.01)	3.65	4.34	4.92	4.72	3.53
	Net income	85	29	(96)	45	1	71	87	135	13	99
	Depreciation	40	52	67	77	95	99	115	118	153	176
Per share, $
Per share, $	Revenue	23.85	27.76	36.88	37.93	38.14	30.72	27.62	21.84	24.69	26.01
	Earnings	0.20	(1.64)	(4.96)	(2.27)	(3.19)	(1.12)	(0.59)	(0.09)	(1.33)	(0.61)
	Cash flow	2.61	2.50	3.01	2.68	5.06	1.20	1.73	2.34	2.38	2.16
	Capex	(0.81)	(0.61)	(0.43)	(1.16)	0.32	(0.71)	(0.74)	(0.50)	(0.70)	(0.25)
	Free cash flow	1.79	1.89	2.58	1.52	5.38	0.49	0.99	1.84	1.68	1.90
	Book value	6.76	34.51	30.36	28.55	26.99	27.19	31.98	24.16	25.34	24.62
	Shares, m	48	48	48	48	49	72	92	126	126	127
Valuation, ×
Valuation, ×	P/E	81.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	P/S	0.65	0.48	0.27	0.41	0.76	1.74	0.95	1.45	0.86	0.59
	P/B	2.29	0.48	0.43	0.77	1.60	1.96	0.82	1.31	0.84	0.63
	EV/Sales	1.85	1.98	1.47	1.77	2.13	2.88	1.87	2.39	1.85	1.64
	EV/FCF	24.58	29.13	21.07	44.14	15.06	180.77	52.22	28.39	27.18	22.42
Cash, $m
Cash, $m	Operating cash flow	125	121	145	130	247	87	159	294	300	274
	Capex	(39)	(30)	(21)	(56)	16	(52)	(68)	(63)	(88)	(32)
	Free cash flow	86	91	124	74	263	36	91	231	212	242
Balance, $m
Balance, $m	Working capital	175	260	239	127	245	409	428	372	495	535
	Total debt	1,442	2,189	2,327	2,581	2,857	2,939	2,622	2,775	3,370	3,702
	Net debt	1,373	2,014	2,142	2,488	2,539	2,549	2,339	2,579	3,101	3,462
	Shareholders’ equity	325	1,667	1,458	1,378	1,317	1,970	2,941	3,035	3,196	3,131
Returns, %
Returns, %	ROA	0.43	(2.28)	(5.12)	(2.28)	(2.98)	(1.41)	(0.85)	(0.18)	(2.28)	(0.97)
	ROIC	7.24	2.69	1.35	3.81	2.97	4.18	4.09	3.65	3.46	3.69
	ROE	3.04	(9.52)	(19.55)	(10.61)	(16.68)	(5.69)	(2.22)	(0.40)	(5.40)	(2.46)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
BKD Brookdale Senior Living Inc.	$2.4B	— (loss-making)	— (loss-making)	−11.61% (below 0%: shrinking)	n/m	+533.14% (above 0%: growing)	29.94%	11.86%	Compare
MD Pediatrix Medical Group, Inc.	$2.3B	13.1×	11.3×	+4.04% (above 0%: growing)	+6.52% (above 0%: growing)	−6.56% (below 0%: shrinking)	27.16%	11.67%	Compare
ADUS Addus HomeCare Corporation	$2.2B	20.4×	14.9×	+8.01% (above 0%: growing)	+24.17% (above 0%: growing)	+81.74% (above 0%: growing)	32.21%	10.32%	Compare
SGRY Surgery Partners, Inc.	$1.9B	— (loss-making)	— (loss-making)	+2.75% (above 0%: growing)	n/m	−60.63% (below 0%: shrinking)	22.41%	12.78%
ASTH Astrana Health, Inc.	$1.9B	44.3×	29.7×	+48.52% (above 0%: growing)	+110.53% (above 0%: growing)	−67.74% (below 0%: shrinking)	10.70%	3.53%	Compare
ARDT Ardent Health, Inc.	$1.7B	21.7×	7.7×	−1.40% (below 0%: shrinking)	−76.92% (below 0%: shrinking)	+121.70% (above 0%: growing)	100.00%	3.44%	Compare
SNDA Sonida Senior Living, Inc.	$1.7B	— (loss-making)	— (loss-making)	+122.02% (above 0%: growing)	n/m	−291.70% (below 0%: shrinking)	34.97%	(2.63%)	Compare
CMPS COMPASS Pathways PLC Sponsored ADR	$1.6B	— (loss-making)	—	—	n/m	−4.18% (below 0%: shrinking)	—	0.00%	Compare
AMN AMN Healthcare Services Inc	$1.6B	15.0×	31.2×	+2.29% (above 0%: growing)	n/m	−389.43% (below 0%: shrinking)	30.58%	4.00%	Compare
Median of peers	$1.8B	20.4×	14.9×	+4.04%	+15.35%	−5.37%	30.58%	3.77%

All 55 Medical Care Facilities stocks →

Surgery Partners, Inc. (SGRY) key facts

Strength: Surgery Partners, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 6.24% from fiscal 2024.
Surgery Partners, Inc. (SGRY) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
As of October 16, 2026, SGRY traded at $14.64, a market capitalization of $1.9 billion.
Return on equity was −2.46% and debt-to-equity 1.21.
Its Piotroski F-score is 4 out of 9 and its Altman Z-score is 0.75 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.